These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17045808)

  • 1. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis.
    Andries M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurobiol Dis; 2007 Jan; 25(1):8-16. PubMed ID: 17045808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
    Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
    J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of parvalbumin on excitotoxic motor neuron death.
    Van Den Bosch L; Schwaller B; Vleminckx V; Meijers B; Stork S; Ruehlicke T; Van Houtte E; Klaassen H; Celio MR; Missiaen L; Robberecht W; Berchtold MW
    Exp Neurol; 2002 Apr; 174(2):150-61. PubMed ID: 11922657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
    Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
    J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
    Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
    J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Van Damme P; Leyssen M; Callewaert G; Robberecht W; Van Den Bosch L
    Neurosci Lett; 2003 Jun; 343(2):81-4. PubMed ID: 12759169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.
    Caioli S; Curcio L; Pieri M; Antonini A; Marolda R; Severini C; Zona C
    Neurobiol Dis; 2011 Oct; 44(1):92-101. PubMed ID: 21726643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alpha-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition.
    Van den Bosch L; Van Damme P; Vleminckx V; Van Houtte E; Lemmens G; Missiaen L; Callewaert G; Robberecht W
    Neuropharmacology; 2002 Apr; 42(5):706-13. PubMed ID: 11985829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.
    Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S
    J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
    Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
    Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
    Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.
    Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):605-12. PubMed ID: 16042312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture.
    Spalloni A; Albo F; Ferrari F; Mercuri N; Bernardi G; Zona C; Longone P
    Neurobiol Dis; 2004 Mar; 15(2):340-50. PubMed ID: 15006704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration.
    Rainey-Smith SR; Andersson DA; Williams RJ; Rattray M
    J Neurochem; 2010 May; 113(3):692-703. PubMed ID: 20132465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
    Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.